Pace® Life Sciences Acquires Velesco Pharmaceutical Services
Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use […]
Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use […]
Acquisition allows Pace to support a growing number of clients requiring services throughout the drug development process while adding expertise
The installation and validation of our LabVantage Laboratory Information Management System (LIMS) is complete in our Philadelphia site! Staff
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Drug Development and Delivery recently interviewed our very own, Frank Tagliaferri,
Pace Analytical® Chief Compliance Officer Appointed to California Environmental Laboratory Technical Advisory Committee Judy Morgan of Pace joins group providing
Summary: In an effort to improve stability and shelf life of a drug, the active ingredients in many therapeutics are
Thursday, October 15, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Event Overview: Determining the polymorphism of a
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides Oligonucleotides are an emerging class of DNA and RNA therapeutics that address a
Check out Nishan Shah, Ph.D’s publication in AAPS News Magazine! Read More…
ON DEMAND WEBINAR: Integrated CMC Development of Gene Therapies Therapeutics that manipulate gene expression are a rapidly growing segment of